Parkside Investments LLC trimmed its position in shares of CME Group Inc (NASDAQ:CME) by 23.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,190 shares of the financial services provider’s stock after selling 6,825 shares during the period. CME Group makes up approximately 1.8% of Parkside Investments LLC’s holdings, making the stock its 9th biggest holding. Parkside Investments LLC’s holdings in CME Group were worth $3,776,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. GHP Investment Advisors Inc. raised its holdings in shares of CME Group by 6.6% during the 3rd quarter. GHP Investment Advisors Inc. now owns 5,996 shares of the financial services provider’s stock worth $1,021,000 after acquiring an additional 369 shares in the last quarter. Guinness Asset Management Ltd raised its holdings in shares of CME Group by 6.1% during the 3rd quarter. Guinness Asset Management Ltd now owns 92,100 shares of the financial services provider’s stock worth $15,676,000 after acquiring an additional 5,310 shares in the last quarter. Forte Capital LLC ADV raised its holdings in shares of CME Group by 5.5% during the 3rd quarter. Forte Capital LLC ADV now owns 25,945 shares of the financial services provider’s stock worth $4,416,000 after acquiring an additional 1,345 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of CME Group by 13.4% during the 3rd quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock worth $20,912,000 after acquiring an additional 14,534 shares in the last quarter. Finally, RWC Asset Management LLP raised its holdings in shares of CME Group by 25.7% during the 3rd quarter. RWC Asset Management LLP now owns 88,000 shares of the financial services provider’s stock worth $14,978,000 after acquiring an additional 18,000 shares in the last quarter. 84.03% of the stock is currently owned by institutional investors and hedge funds.

In other CME Group news, CAO Jack J. Tobin sold 7,820 shares of the firm’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $174.87, for a total value of $1,367,483.40. Following the completion of the sale, the chief accounting officer now owns 17,534 shares of the company’s stock, valued at $3,066,170.58. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, President Bryan T. Durkin sold 11,509 shares of the firm’s stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $162.01, for a total value of $1,864,573.09. Following the completion of the sale, the president now directly owns 64,862 shares of the company’s stock, valued at approximately $10,508,292.62. The disclosure for this sale can be found here. In the last three months, insiders sold 29,188 shares of company stock valued at $4,973,607. Corporate insiders own 0.43% of the company’s stock.

CME has been the topic of several recent research reports. Jefferies Financial Group restated a “buy” rating and set a $190.00 price target on shares of CME Group in a report on Wednesday, September 5th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a report on Wednesday, August 22nd. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a report on Saturday, August 18th. Rosenblatt Securities assumed coverage on CME Group in a report on Wednesday, September 5th. They set a “neutral” rating and a $177.00 price target on the stock. Finally, Berenberg Bank set a $184.00 target price on CME Group and gave the stock a “hold” rating in a research note on Thursday, September 20th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $181.38.

CME stock traded up $3.28 during trading on Wednesday, reaching $181.34. 81,319 shares of the company traded hands, compared to its average volume of 1,566,123. CME Group Inc has a 12 month low of $132.33 and a 12 month high of $182.97. The company has a market cap of $57.79 billion, a P/E ratio of 37.39, a PEG ratio of 3.20 and a beta of 0.64. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.08 and a quick ratio of 1.08.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.02. CME Group had a return on equity of 9.03% and a net margin of 111.45%. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter last year, the company earned $1.22 earnings per share. The firm’s revenue for the quarter was up 14.6% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc will post 6.64 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 25th. Shareholders of record on Monday, September 10th were issued a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 1.54%. The ex-dividend date was Friday, September 7th. CME Group’s dividend payout ratio is presently 58.70%.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: How Investors Use a Balance Sheet

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.